<DOC>
	<DOCNO>NCT02906683</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety TAS-303 female patient stress urinary incontinence .</brief_summary>
	<brief_title>Exploratory Trial TAS-303 Female Patients With Stress Urinary Incontinence</brief_title>
	<detailed_description>The main purpose study assess efficacy TAS-303 8 week female patient stress urinary incontinence ( SUI ) compare placebo measure percent change incontinence episode frequency ( IEF ) baseline .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Patient symptom Stress Urinary Incontinence ( SUI ) least 12 week prior study entry Patient least 1 incontinence episode per day , urinary diurnal frequency 10 less per day nocturia 2 less per day . Patient positive 1hour pad weight test Patient predominant primary urge incontinence accord investigator judgment Patient prior surgical SUI treatment Patient diagnose stageII Pelvic Organ Prolapse Patient symptom Urinary tract infection ( UTI ) Patient positive pregnancy test Patient physical examination , neurological and/or vaginal examination result , opinion investigator , exclude subject .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Urinary Incontinence</keyword>
	<keyword>Urinary Incontinence , Stress</keyword>
	<keyword>Lower Urinary Tract Symptoms</keyword>
</DOC>